The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase II multi-center study of individualized axitinib (Axi) titration for metastatic renal cell carcinoma (mRCC) after treatment with PD-1 / PD-L1 inhibitors.
 
Moshe Chaim Ornstein
Consulting or Advisory Role - Eisai; Pfizer
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Laura S. Wood
Consulting or Advisory Role - Exelixis; Merck
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Novartis; Pfizer
 
Kimberly D Allman
Speakers' Bureau - Exelixis; Pfizer; Sanofi
 
Allison Martin
No Relationships to Disclose
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - WellPoint
 
Donna Company
No Relationships to Disclose
 
Thomas Olencki
Research Funding - Bristol-Myers Squibb (Inst); Immunocore (Inst); Pfizer (Inst); Regeneron (Inst)
 
Kimryn Rathmell
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Incyte (I); Merck (I); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer